This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kitabchi, A. E. Articles by Umpierrez, G. E. Search for Related Content PubMed PubMed Citation Articles by Kitabchi, A. E. Articles by Umpierrez, G. E.

Changes in Serum Leptin in Lean and Obese Subjects with Acute Hyperglycemic Crises

Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, Tennessee 38163

Address all correspondence and requests for reprints to: Abbas E. Kitabchi, Ph.D., M.D., Professor of Medicine and Molecular Sciences, University of Tennessee Health Science Center, 951 Court Avenue, Room 335M, Memphis, Tennessee 38163. E-mail: akitabchi{at}utmem.edu.

We aimed to determine the effect of insulin replacement on serum leptin concentration in lean and obese patients with diabetic ketoacidosis (DKA). We compared serial leptin levels in 52 patients with DKA, 14 obese subjects with hyperglycemia, and 52 nondiabetic control subjects. Leptin levels on admission were significantly decreased in lean and obese patients with DKA and/or hyperglycemia compared with weight- and gender-matched controls. Insulin therapy resulted in a significant increase in leptin levels within 4 h, with peak stimulation at 12 h. Leptin levels on admission and at resolution of hyperglycemia were higher in obese DKA (9.7 ± 2 ng/ml and 26.5 ± 5 ng/ml, respectively; P < 0.001) and obese hyperglycemia subjects (11.9 ± 4 ng/ml vs. 24.4 ± 2 ng/ml; P < 0.001) than in lean DKA subjects (5.3 ± 0.3 ng/ml and 10.1 ± 2 ng/ml; P < 0.001).

We conclude that insulin treatment in patients with acute hyperglycemic crises is followed by rapid and significant increase in leptin concentration, and this increase is more discernible in obese subjects. The low serum leptin level on admission in subjects with hyperglycemic crises may be the result of impaired adipocyte glucose utilization due to insulin deficiency and/or to increased catecholamine levels.

This work was supported in part by a clinical research grant from the American Diabetes Association (to A.E.K.).

Abbreviations: BMI, Body mass index; DKA, diabetic ketoacidosis; FFA, free fatty acids.

This article has been cited by other articles:

				A. E. Kitabchi, G. E. Umpierrez, J. N. Fisher, M. B. Murphy, and F. B. Stentz Thirty Years of Personal Experience in Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1541 - 1552. [Abstract] [Full Text] [PDF]

				F. B. Stentz, G. E. Umpierrez, R. Cuervo, and A. E. Kitabchi Proinflammatory Cytokines, Markers of Cardiovascular Risks, Oxidative Stress, and Lipid Peroxidation in Patients With Hyperglycemic Crises Diabetes, August 1, 2004; 53(8): 2079 - 2086. [Abstract] [Full Text] [PDF]